Highlights BeiGene, Ltd.

Equities

BGNE

US07725L1026

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 01:30:00 20/09/2024 am IST			5-day change	1st Jan Change
198.59 ^USD	+0.66%		+1.18%	+10.11%

18/09	JMP Securities Initiates BeiGene at Outperform With $288 Price Target	MT
17/09	BeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA® for the Treatment of Oesophageal Squamous Cell Carcinoma After Prior Chemotherapy	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JMP Securities Initiates BeiGene at Outperform With $288 Price Target	18/09	MT
BeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA® for the Treatment of Oesophageal Squamous Cell Carcinoma After Prior Chemotherapy	17/09	CI
Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading	12/09	MT
Asian Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading	11/09	MT
BeiGene Grants Share Options, RSUs under Incentive Plan	05/09	MT
BeiGene's H1 Loss Narrows as Revenue Rises	27/08	MT
Sector Update: Health Care Stocks Higher Pre-Bell Monday	26/08	MT
Sector Update: Health Care	26/08	MT
BeiGene Says BGB-16673 Gets FDA Fast Track Status for Lymphocytic Leukemia, Lymphoma	26/08	MT
BeiGene Narrows H1 Loss on Higher Product Sales; Hong Kong Shares Gain 3%	08/08	MT
BeiGene Shrinks Loss in Fiscal Q2 Amid 56% Revenue Boost	07/08	MT
BeiGene' Q2 Net Loss Narrows, Revenue Rises; Shares Gain	07/08	MT
Earnings Flash (BGNE) BEIGENE Posts Q2 Revenue $929.2M	07/08	MT
BeiGene, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	07/08	CI
BeiGene Opens Flagship US Biologics Manufacturing Facility in New Jersey	23/07	MT
BeiGene Opens U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World	23/07	CI
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading	12/07	MT
Asian Equities Traded in the US as American Depositary Receipts Open Week on Flat Note	01/07	MT
BeiGene Says New Phase 3 Brukinsa Data Show 'Promising' Efficacy in Leukemia, Lymphoma	14/06	MT
BeiGene to Present New Data from SEQUOIA Study Evaluating BRUKINSA® plus Venetoclax in High-Risk First-Line CLL/SLL at EHA2024	14/06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights BeiGene, Ltd.

Equities

BGNE

US07725L1026

Biotechnology & Medical Research

Highlights

Filters